Total Wellness’s Direct Supplier of Flu Vaccine, Sanofi, Approved by FDA for New Flu Vaccine Manufacturing Facility

Total Wellness's direct supplier of flu vaccine, Sanofi Pasteur, was announced today by the U.S. Food and Drug Administration (FDA) that it has approved a new manufacturing facility used to produce influenza virus vaccines. The facility is approved for seasonal influenza vaccine production and could be used for the production of vaccine against the new 2009 H1N1 influenza strain.

The facility, located in the United States, is owned and operated by sanofi pasteur, which manufactures Fluzone Influenza Virus Vaccine. This new facility will greatly increase sanofi pasteur’s production capability.

As part of its overall pandemic influenza preparedness efforts, the FDA meets with vaccine manufacturers to guide the efficient establishment of influenza vaccine facilities that comply with agency requirements. The agency promptly reviews applications and manufacturing supplements that could increase both the number of manufacturers and the overall supply of vaccine.

To read full article on CDC website please visit:

FDA Approves New Influenza Vaccine Production Facility